Medipharm Labs Corp
TSX:LABS

Watchlist Manager
Medipharm Labs Corp Logo
Medipharm Labs Corp
TSX:LABS
Watchlist
Price: 0.07 CAD 7.69% Market Closed
Market Cap: 29.5m CAD

Wall Street
Price Targets

LABS Price Targets Summary
Medipharm Labs Corp

There are no price targets for LABS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Medipharm Labs Corp Competitors:
Price Targets
PBH
Prestige Consumer Healthcare Inc
29% Upside
086450
Dongkook Pharmaceutical Co Ltd
38% Upside
CURA
Curaleaf Holdings Inc
3% Downside
VY4
SNDL Inc
173% Upside
200670
Humedix Co Ltd
68% Upside
ZYDUSLIFE
Zydus Lifesciences Ltd
12% Upside
4577
Daito Pharmaceutical Co Ltd
8% Downside
DHG
Dhg Pharmaceutical Joint-Stock Co
8% Upside

Revenue
Forecast

Revenue Estimate
Medipharm Labs Corp

For the last 5 years the compound annual growth rate for Medipharm Labs Corp's revenue is -20%. The projected CAGR for the next 2 years is 14%.

-20%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Medipharm Labs Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
10%
Average Beat

Net Income
Forecast

Net Income Estimate
Medipharm Labs Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LABS's stock price target?
Not Available

LABS doesn't have any price targets made by Wall Street professionals.

What is Medipharm Labs Corp's Revenue forecast?
Projected CAGR
14%

For the last 5 years the compound annual growth rate for Medipharm Labs Corp's revenue is -20%. The projected CAGR for the next 2 years is 14%.

Back to Top